SCHEMBL7259138

SCHEMBL7259138

Brc1n[nH]c2nnc(-c3ccccc3)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 11/20 0.54
GSK3B P49841 8/20 0.50
CCNB2 O95067 1/20 0.50
CDK1 P06493 1/20 0.50
CCNB1 P14635 1/20 0.50
CCNB3 Q8WWL7 1/20 0.50
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
SMARCA2 P51531 1/20 0.40
SMARCA4 P51532 1/20 0.40
PBRM1 Q86U86 1/20 0.40
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
DCLK1 O15075 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
CHEK2 O96017 1/20 0.38
CSF1R P07333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255610 0.83 GSK3A (0.53) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7256481 0.81 DCLK1 (0.51) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL1460319 0.81 GSK3A (0.59) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7255584 0.80 GABRG2 (0.49) GSK3AGSK3BCCNB2CDK1CCNB1
Hydrazine SCHEMBL7155128 0.79 GSK3A (0.56) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7256577 0.76 GSK3A (0.54) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7261231 0.75 GSK3A (0.50) GSK3AGSK3BCCNB2CDK1CCNB1
Water SCHEMBL7155130 0.74 GSK3A (0.55) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7260051 0.74 GSK3A (0.46) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL7260215 0.74 GSK3A (0.46) GSK3AGSK3BCCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003080616-A1 PYRAZOLOPYRIDAZINE DERIVATIVES, PROCESS FOR PREPARATION AND USE FOR THE INHIBITION OF GSK-3 GLAXO GROUP LIMITED (GB) 2003-10-02 WO disclosed